` Comparison: XTLB vs ATXS - Alpha Spread

X
XTLB
vs
ATXS

Over the past 12 months, XTLB has underperformed ATXS, delivering a return of -49% compared to the ATXS's +87 326% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
XTLB
ATXS
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

X
XTLB Intrinsic Value
Not Available
ATXS Intrinsic Value
75.09 USD
Overvaluation 99%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
X
X T L Biopharmaceuticals Ltd
TASE:XTLB
2.2 ILS
Astria Therapeutics Inc
NASDAQ:ATXS
5 298 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
XTLB, ATXS

XTLB
ATXS
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
X
X T L Biopharmaceuticals Ltd
Revenue
Astria Therapeutics Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
XTLB, ATXS

XTLB
ATXS
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
X
X T L Biopharmaceuticals Ltd
TASE:XTLB
Astria Therapeutics Inc
NASDAQ:ATXS
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

XTLB
0%
ATXS
0%

Operating Margin

XTLB
0%
ATXS
-19 335.7%

Net Margin

XTLB
0%
ATXS
-17 568%

FCF Margin

XTLB
0%
ATXS
-17 042.9%

ROE

XTLB
39.8%
ATXS
-43.1%

ROA

XTLB
38.8%
ATXS
-39.2%

ROIC

XTLB
-28.1%
ATXS
-462.1%

ROCE

XTLB
-10.4%
ATXS
-45.9%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
XTLB, ATXS

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
XTLB, ATXS

Loading
XTLB
ATXS
Difference
www.alphaspread.com

Performance By Year
XTLB, ATXS

Loading
XTLB
ATXS
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare XTLB to other stocks
PNEXF
Pharnext SCA
More expensive
vs XTLB
ABBV
Abbvie Inc
Cheaper
vs XTLB
EXAS
Exact Sciences Corp
Cheaper
vs XTLB
AMGN
Amgen Inc
Cheaper
vs XTLB
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett